June 2020 FDA Recall Drug by The Harvard Drug Group
D-1360-2020 - CGMP Deviation

This Class II drug recall was voluntarily initiated by The Harvard Drug Group on June 12, 2020 for the product Drug. The FDA reported the reason for recall as cgmp deviation. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1360-2020

Reason for Recall
CGMP Deviation: Potential presence of Nitrosodimethylamine (NDMA) Impurity above the established levels.
Initiated
06-12-2020
Reported
07-08-2020
Quantity
1,906 Cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
The Harvard Drug Group
Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 100 Tablets (10 x 10) unit dose cartons, Rx only, Manufactured by: Apotex, Inc., Toronto, Ontario, Canada, Manufactured for: Apotex Corp. Weston, FL, Distributed by: Major Pharmaceuticals, Livonia, MI 48152 NDC 00904-5794-61

Batch or Lot Expiration Information

Lot# Lot T-02134, exp 09/2020